Mirikizumab, Mirikizumab, Mirikizumab
I6T-MC-AMAX
Phase 3 small_molecule active
Quick answer
Mirikizumab, Mirikizumab, Mirikizumab for Crohn’s Disease is a Phase 3 program (small_molecule) at Eli Lilly Co. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Eli Lilly Co.
- Indication
- Crohn’s Disease
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active